Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior

doi:10.19401/j.cnki.1007-3639.2023.05.004

Abstract

Abstract:

Background and purpose: Circular RNA (circRNA) plays an important regulatory role in the development of a variety of tumors. However, the abnormal expression and biological function of circRNA in nasopharyngeal carcinoma remain unclear. This study aimed to explore the effect of hsa_circ_0012779 on the biological behavior of nasopharyngeal carcinoma cells and its molecular mechanism. Methods: The expression of hsa_circ_0012779 in human immortalized nasopharyngeal epithelial cell line NP69 and nasopharyngeal carcinoma cell lines CNE2, 5-8F, HNE1 and SUNE1 was detected by real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR). Cell counting kit-8 (CCK-8) assay and transwell invasion assay were used to detect the effect of hsa_circ_0012779 on the proliferation and invasion ability of nasopharyngeal carcinoma cells. The protein level of ELAV like protein 1 (ELAVL1) in NPC cells with hsa_circ_0012779 knockdown was detected by Western blot. The binding of hsa_circ_0012779 and ELAVL1 was verified by RNA pull-down assay. Results: hsa_circ_0012779 was highly expressed in nasopharyngeal carcinoma tissues and cells. Knockdown hsa_circ_0012779 could inhibit the proliferation and invasion of nasopharyngeal carcinoma cells. hsa_circ_0012779 bound to RNA-binding protein ELAVL1 to promote its expression and colocalization in cytoplasm. In the meanwhile, the effect of knockdown hsa_circ_0012779 on nasopharyngeal carcinoma cells could be reversed by the overexpression of ELAVL1. Conclusion: hsa_circ_0012779 promote the expression of ELAVL1 and thus promote the proliferation and invasion of nasopharyngeal carcinoma, and influence the occurrence and development of nasopharyngeal carcinoma.

Key words: Circular RNA, Nasopharyngeal carcinoma, hsa_circ_0012779, ELAV like protein 1, Proliferation, Invasion

CLC Number:

R739.6

ZHANG Pingchuan, DU Mingyu, YAO Chengyun, HE Xia, YIN Li. Mechanism of circular RNA hsa_circ_0012779 expression in nasopharyngeal carcinoma and its influence on cell biological behavior[J]. China Oncology, 2023, 33(5): 445-451.

Figures/Tables 4

Fig. 1

Fig. 2

Fig. 3

Fig.4

References 13

[1]	CHEN Y P, CHAN A T C, LE Q T, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi: 10.1016/S0140-6736(19)30956-0
[2]	LEE A W, MA B B, NG W T, et al. Management of nasopharyngeal carcinoma: current practice and future perspective[J]. J Clin Oncol, 2015, 33(29): 3356-3364. doi: 10.1200/JCO.2015.60.9347 pmid: 26351355
[3]	VO J N, CIESLIK M, ZHANG Y J, et al. The landscape of circular RNA in cancer[J]. Cell, 2019, 176(4): 869-881.e13. doi: S0092-8674(18)31635-0 pmid: 30735636
[4]	WANG J, KONG J Y, NIE Z, et al. Circular RNA Hsa_circ_0066755 as an oncogene via sponging miR-651 and as a promising diagnostic biomarker for nasopharyngeal carcinoma[J]. Int J Med Sci, 2020, 17(11): 1499-1507. doi: 10.7150/ijms.47024 pmid: 32669952
[5]	JIANG C, LI H Y, LIU F, et al. Hsa_circ_0000345 inhibits cell proliferation, migration and invasion of nasopharyngeal carcinoma cells via miR-513a-3p/PTEN axis[J]. J Physiol Sci, 2022, 72(1): 10. doi: 10.1186/s12576-022-00834-4 pmid: 35545766
[6]	LI X, YANG L, CHEN L L. The biogenesis, functions, and challenges of circular RNAs[J]. Mol Cell, 2018, 71(3): 428-442. doi: S1097-2765(18)30509-4 pmid: 30057200
[7]	OKHOLM T L H, SATHE S, PARK S S, et al. Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression[J]. Genome Med, 2020, 12(1): 112. doi: 10.1186/s13073-020-00812-8 pmid: 33287884
[8]	PALOMO-IRIGOYEN M, PÉREZ-ANDRÉS E, IRUARRIZAGA-LEJARRETA M, et al. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis[J]. J Clin Invest, 2020, 130(7): 3848-3864. doi: 10.1172/JCI130379
[9]	CAI Z L, XU H, BAI G, et al. ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators[J]. Front Oncol, 2022, 12: 939784. doi: 10.3389/fonc.2022.939784
[10]	HU W Q, LI H L, WANG S Z. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis[J]. BMC Cancer, 2020, 20(1): 376. doi: 10.1186/s12885-020-06775-8 pmid: 32370736
[11]	D’AGOSTINO V G, ADAMI V, PROVENZANI A. A novel high throughput biochemical assay to evaluate the HuR protein-RNA complex formation[J]. PLoS One, 2013, 8(8): e72426.
[12]	AL-HABEEB F, ALOUFI N, TRABOULSI H, et al. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production[J]. J Cell Physiol, 2021, 236(10): 6836-6851. doi: 10.1002/jcp.v236.10
[13]	DOLLER A, AKOOL E L S, HUWILER A, et al. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin Ⅱ-induced stabilization and nuclear export of cyclooxygenase 2 mRNA[J]. Mol Cell Biol, 2008, 28(8): 2608-2625. doi: 10.1128/MCB.01530-07

[1]	WANG Xuemei, CHENG Yu, QI Jiemin. PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway [J]. China Oncology, 2023, 33(5): 437-444.
[2]	XIAO Lanshu, PAN Liudi, LIU Yi, WANG Jie, CHEN Hui. LncRNA DLEU7-AS1 contributes to proliferation and migration of gastric cancer by regulating MSN transcription [J]. China Oncology, 2023, 33(4): 327-341.
[3]	CHEN Hong, CHEN Junxia. Effect of hsa_circ_0001573 on biological behaviors of breast cancer cells and its molecular mechanism [J]. China Oncology, 2023, 33(4): 342-353.
[4]	PENG Jin, WANG Weining, TAN Zhi, YE Guannan, ZHOU Zhen. The mechanism of m6Am-modifying enzyme PCIF1 regulating target gene ACOT8 in gastric cancer progression [J]. China Oncology, 2023, 33(4): 368-376.
[5]	FU Qingsheng, JIN Lei, ZHANG Xudong, XU Yingchen, ZHU Chunfu, QIN Xihu, WU Baoqiang. Effect of tRF-Pro-CGG on the biological behavior of mouse pancreatic cancer cells and its molecular mechanism [J]. China Oncology, 2023, 33(3): 241-249.
[6]	TANG Tianci, ZHAI Zhoushijia, LI Shengwei, WANG Xiaoshen, NI Xiaochen. Application of generalized equivalent uniform dose optimization in the treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy [J]. China Oncology, 2023, 33(3): 274-281.
[7]	WANG Xiaoxiao, CHEN Xi, LI Minmin, SONG Ning, SUN Dongyuan, JIANG Yingying. Effects of NOL8 on cell proliferation, migration and invasion of oral squamous cell carcinoma [J]. China Oncology, 2023, 33(1): 45-53.
[8]	ZHANG Jingchen, LI Xin, LI Jiangtao, LI Haiping, CHEN Yanli, NIU Bing, QI Chuanchuan, YE Beibei. LINC02163 targeting miR-338-3p affects proliferation, invasion and migration of breast cancer cells [J]. China Oncology, 2022, 32(9): 818-826.
[9]	CAI Juan, CHEN Zhiqiang, ZUO Xueliang. CircSMARCA5 inhibits glycolysis and suppresses proliferation and invasion of gastric cancer cells through miR-4295/PTEN axis [J]. China Oncology, 2022, 32(4): 298-308.
[10]	MA Guang, OU Xiaomin, HU Chaosu, SONG Shaoli, YANG Zhongyi. Value of pretreatment ¹⁸F-FLT PET/CT and ¹⁸F-FDG PET/CT uptake heterogeneity for early prediction of treatment outcome in locally advanced nasopharyngeal carcinoma [J]. China Oncology, 2022, 32(4): 309-315.
[11]	DUAN Yuqing, XIA Ning, JIA Yunlong, ZHENG Wenya, LIU Lihua. SRSF1 promotes proliferation, invasion and migration of esophageal squamous cell carcinoma Eca9706 cells by regulating VEGFA mRNA alternative splicing [J]. China Oncology, 2022, 32(3): 191-199.
[12]	ZHU Haipeng, HU Jun, JIANG Min, CAI Ruonan, WANG Junqiao, LI Li. A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells [J]. China Oncology, 2022, 32(3): 207-217.
[13]	CHEN Xi, ZENG Xiaoying, CHEN Jiayan, LIU Fei, TANG Xi. The clinical value of mismatch repair protein combined with serum tumor markers and Ki-67 proliferation index in the prognostic evaluation of colorectal cancer [J]. China Oncology, 2022, 32(3): 243-250.
[14]	WANG Jun, HE Ping. Prognostic value of perineural invasion in ypⅠ-Ⅱ rectal cancer patients who received neoadjuvant radiotherapy [J]. China Oncology, 2022, 32(12): 1229-1234.
[15]	ZHU Yi, XIAO Bin, LIU Jiahui, HUANG Ling, SUN Zhaohui, LI Linhai. Expression, localization, biological role and proteomics study of circ-0003910 in HER2-positive breast cancer [J]. China Oncology, 2022, 32(10): 979-989.